| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |